.Merck defeats profits desires, raises purchases overview on powerful need for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Forecasts as Keytruda Purchases Surge BloombergMerck Supply: Pharma Titan Posts Solid Outcomes, But Expectation Tumbles Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats earnings and sales assumptions in the middle of Keytruda advantage, yet gives combined full-year overview MarketWatch.